by Ben Young and Andrew Pouw
Email Addresses
0 available
Phone Numbers
0 available
March 11, 2024
<p>Ben and Andrew review toxocariasis and its gnarly lifecycle, why every ophthalmologist needs to know about it, treatment, and more.</p> <p> </p> <p>We wish everyone about to take OKAPs the best of luck!</p>
March 4, 2024
<p>Ben and Amanda review VKH, including terminology, key findings, stages, and differential diagnoses.</p>
February 26, 2024
<p>Ben and Andrew review how oculocutaneous and ocular albinism affect the eye, genetics of these problems, and other systemic conditions that cause albinism.</p>
American Academy of Ophthalmology
American Academy of Ophthalmology
MayoClinicOphthalmology
Eyetube
Cataract Coach with Uday Devgan MD
Eyetube
Drs. Akshay Thomas & Laura Kopplin.
JAMA Network
Hidden Brain, Shankar Vedantam
Freakonomics Radio + Stitcher
Retina Today
Dr. Jim Dahle of the White Coat Investor
Peter Attia, MD
NPR
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.